Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,878 stories, page 578 of 732

Advanced search

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Endevica spinout Kalohexis submits confidential IPO filing to develop obesity challenger to GLP-1s

Fierce BiotechOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Celea Therapeutics lands $180 million to launch first head-to-gead Phase 3 IPF trial

Indian Pharma PostOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

SLS Stock: SELLAS Investors Look For More After 542% Surge

CMC MarketsOriginal source

🇺🇰Jul 7Regulatorygov.ukTier 1 · Regulatory source

New heart disease and strokes plan to save thousands of lives

National framework launched to help reduce premature deaths from heart disease and strokes by a quar...

UK Department of Health and Social CareOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

SLS Stock: SELLAS Investors Look For More After 542% Surge

CMC MarketsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Sen. Rick Scott wants pharmaceutical tariff carve-out reversed over China’s forced labor

Washington TimesOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics

markets.businessinsider.comOriginal source

🇩🇪Jul 7Researchuk-essen.deTier 2 · Direct publisher

Auszeichnung „BABYFREUNDLICH“: Perinatalzentrum des UK Essen von WHO und UNICEF zertifiziert

Universitätsklinikum EssenOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Obesity biotech Kalohexis files confidential IPO

pharmaphorumOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

Saol Therapeutics Resubmits the New Drug Application for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD), an Ultra-Rare Disease

BioSpaceOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

World Retinoic Acid - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source

🇺🇰Jul 7Regulatorygov.ukTier 1 · Regulatory source

Cardiovascular disease modern service framework

Documents relating to the cardiovascular disease modern service framework.

UK Department of Health and Social CareOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Crinetics Pharmaceuticals Acquired by Fortress Biotech for $10 B

GuruFocusOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk signs agreement with biotech company to evaluate semaglutide implant

medwatch.comOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Purely Golden Foods brings biopharma rigor to pet nutrition - Bizwomen

The Business JournalsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Former Vertex, GSK exec launches science-first pet nutrition company

The Business JournalsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Obesity biotech Kalohexis confidentially files to go public in US

TradingViewOriginal source

🇪🇺Jul 7Researchectrims.euTier 2 · Direct publisher

MS Spotlight: Person at the Centre of Care

ECTRIMS MSOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

NICE recommends Endosure and Endotest diagnostics for endometriosis

Fierce BiotechOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Bioray Biotech Co., Ltd – TPEX:7561

TradingViewOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

De-risking drug formulation with AI predictive modelling

Pharmaceutical TechnologyOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Kymera hires ex-Sanofi executive to lead KT-621 development

Investing.com UKOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

The Role of Standards in the Drug Supply Chain

PharmTech.comOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Absentia Labs' Digital Liver Model Becomes First AI Drug Development Tool Accepted Into FDA Qualification Program

MorningstarOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Theriva™ Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

The Manila TimesOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1

The Manila TimesOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of IO Biotech, Inc. – OTC:IOBTQ

TradingViewOriginal source

🇨🇦Jul 7Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

TAVNEOS (avacopan) and Health Canada’s Review of Data Integrity Concerns

Health Canada is reviewing significant concerns regarding the data integrity of the pivotal ADVOCATE...

Health Canada Recalls and Safety AlertsOriginal source

🌍Jul 7Researchpremier-research.comTier 2 · Direct publisher

Patient-Centered Execution Across Cell, Gene, and RNA Therapeutics

Premier ResearchOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Theriva wins Spain nod for more frequent VCN-01 dosing in pancreatic cancer trial

Stock TitanOriginal source

🌍Jul 7Industryinvestors.vivani.comTier 1 · Company source

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Vivani MedicalOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Dear Doctor: Is it true pharmaceutical companies are suppressing peptides because of competition?

Syracuse.comOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Oculgen enrolls first US patient in global phase 2/3 wet AMD trial

Eyes On EyecareOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535

The Manila TimesOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

The Manila TimesOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

The Manila TimesOriginal source

🌍Jul 7Industrypiindustries.comTier 1 · Company source

Powering an Integrated, Data-Driven Enterprise at PI with SAP S/4Hana

PI Industries (Pharma)Original source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

What do I need to know about daraxonrasib, the new treatment for pancreatic cancer?

Those Nerdy GirlsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

FDA backs single Phase 3 trial for Alterity’s MSA drug ATH434

Stock TitanOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Axsome starts Phase 3 ADHD trial in children, enrolling 468 patients

Stock TitanOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Kailera's oral GLP-1 pill posted 11.1% weight loss in Phase 3

Stock TitanOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Annovis enrolls 850 patients in Phase 3 Alzheimer’s study

Stock TitanOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535

Yahoo FinanceOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease

GlobeNewswireOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Shanghai-Hong Kong Bootcamp Selects AI and Biotech Projects

Let's Data ScienceOriginal source

🇺🇰Jul 7Regulatorygov.ukTier 1 · Regulatory source

DHSC: spending over £25,000, February 2026

Reports on departmental spending over £25,000.

UK Department of Health and Social CareOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Brandon Capital scores its biggest return ever with $2.1bn biotech acquisition

Forbes AustraliaOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

RCS - Intnl. Biotechnology - Portfolio company Crinetics acquired by Vertex

TradingViewOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Compass Pathways says second psilocybin trial kept depression benefit for 6 months

Stock TitanOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile

Via TTOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market

Pharmaceutical ExecutiveOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Ono Pharmaceutical Co. (OPHLF) Moves 10.4% Higher: Will This Strength Last?

Yahoo FinanceOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

CMG Pharmaceutical Co., Ltd. announced that it has received KRW 45 billion in funding from Korea Investment & Securities Co., Ltd.

marketscreener.comOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

FDA outlines single Phase 3 trial plan for Alterity (NASDAQ: ATHE) ATH434

Stock TitanOriginal source

🌍Jul 7discoverynews.google.comTier 2 · Trade media

UK biotechs struggling to access finance as scale-up concerns grow

Pharmaceutical TechnologyOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

West to Host Second-Quarter 2026 Conference Call

TradingViewOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Why Maharashtra FDA Banned Compulsory Hospital Pharmacy Purchases

LatestLYOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

How Do Analysts Rate This Biotech Focused on Chronic Inflammatory Diseases?

Streetwise ReportsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

French Clinical-Stage Biotech's UC Drug Faces 'Best in Disease' Doubts as Analyst Lifts Target Ahead of 4Q26 FDA Filing

Streetwise ReportsOriginal source

🌍Jul 7discoverynews.google.comTier 3 · Aggregated media

Sanyou and Baiyunshan Xihe sign radiopharma deal

The Pharma LetterOriginal source